Literature DB >> 11895620

T cells in drug allergy.

Werner J Pichler1.   

Abstract

In recent years, increasing evidence has indicated an important role for T cells in various drug-induced diseases. A detailed analysis of patients with various drug allergies revealed the existence of drug-specific T cells in the circulation or in eluate from skin infiltration in bullous, pustular, and maculopapular drug eruptions. The drug-specific T cells use the ab-T cell receptor CD4+ or CD8+ and react with drugs acting as haptens (covalently bound to larger molecules, such as penicillins), but also recognize drugs if they are bound only in a labile way to major histocompatibility complex molecules (noncovalent drug presentation). Functional analysis revealed a predominant IL-5 production by drug-specific CD4+ T cells in maculopapular exanthema (MPE) and bullous skin diseases, while patients with acute generalized exanthematous pustulosis have a peculiar T cell subset secreting high amounts of IL-8. Moreover, in MPE CD4+, perforin+ T cells were found in vitro and in immunohistology that had cytotoxic potential and killed keratinocytes in vitro and in vivo.

Entities:  

Mesh:

Year:  2002        PMID: 11895620     DOI: 10.1007/s11882-002-0032-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

Review 1.  Molecular basis of drug recognition by specific T-cell receptors.

Authors:  S von Greyerz; C Burkhart; W J Pichler
Journal:  Int Arch Allergy Immunol       Date:  1999-07       Impact factor: 2.749

2.  Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions.

Authors:  N Yawalkar; M Shrikhande; Y Hari; H Nievergelt; L R Braathen; W J Pichler
Journal:  J Allergy Clin Immunol       Date:  2000-12       Impact factor: 10.793

3.  Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions.

Authors:  M Blanca; S Posadas; M J Torres; L Leyva; C Mayorga; L Gonzalez; C Juarez; J Fernández; L F Santamaria
Journal:  Allergy       Date:  2000-11       Impact factor: 13.146

4.  Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy.

Authors:  E Padovan; T Bauer; M M Tongio; H Kalbacher; H U Weltzien
Journal:  Eur J Immunol       Date:  1997-06       Impact factor: 5.532

Review 5.  Role of T cells in drug allergies.

Authors:  W J Pichler; B Schnyder; M P Zanni; Y Hari; S von Greyerz
Journal:  Allergy       Date:  1998-03       Impact factor: 13.146

6.  Characterization of lidocaine-specific T cells.

Authors:  M P Zanni; D Mauri-Hellweg; C Brander; T Wendland; B Schnyder; E Frei; S von Greyerz; A Bircher; W J Pichler
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

7.  Sulfamethoxazole is metabolized to the hydroxylamine in humans.

Authors:  A E Cribb; S P Spielberg
Journal:  Clin Pharmacol Ther       Date:  1992-05       Impact factor: 6.875

8.  T cell involvement in cutaneous drug eruptions.

Authors:  Y Hari; K Frutig-Schnyder; M Hurni; N Yawalkar; M P Zanni; B Schnyder; A Kappeler; S von Greyerz; L R Braathen; W J Pichler
Journal:  Clin Exp Allergy       Date:  2001-09       Impact factor: 5.018

Review 9.  T cell immune responses to haptens. Structural models for allergic and autoimmune reactions.

Authors:  H U Weltzien; C Moulon; S Martin; E Padovan; U Hartmann; J Kohler
Journal:  Toxicology       Date:  1996-02-22       Impact factor: 4.221

10.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

View more
  5 in total

1.  Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.

Authors:  Anuska Llano; Christian Brander
Journal:  Cell Res       Date:  2012-07-10       Impact factor: 25.617

Review 2.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.

Authors:  Sanjoy Roychowdhury; Craig K Svensson
Journal:  AAPS J       Date:  2005-12-09       Impact factor: 4.009

3.  [Acute generalized exanthematous pustulosis].

Authors:  A Sidoroff
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

Review 4.  Adverse reactions to neuromuscular blocking agents.

Authors:  Paul-Michel Mertes; Marie Claire Laxenaire
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

5.  A case of acute generalized exanthematous pustulosis associated with polyarteritis nodosa, responding to systemic steroids.

Authors:  Ayham M Alkhachroum; Nayef Kazzaz
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.